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A cytosolic calmodulin wave has been described in the pre-replicative phase of rat liver regeneration. Here we demon- 
strate that this calmodulin increase is reduced by injection of cycloheximide (translation inhibitor) and actinomycin D 
(transcription inhibitor). In addition, we found that calmodulin mRNA levels are increased during the early pre-replic- 
ative period of liver regeneration, and this increase is affected by actinomycin D. Together, these results strongly indicate 
that the calmodulin wave observed in the pre-replicative phase of liver regeneration is due to de novo synthesis of this 
protein. 
Ca2 +-binding protein; Calmodulin: Liver regeneration 
1. INTRODUCTION 
Calcium together with calmodulin is important 
for the initiation of DNA synthesis in normal and 
neoplastic mammalian cells [l-3]. Elevated cal- 
modulin levels have been described in some cell 
lines virally transformed in vitro [4,5]. Elevated 
calmodulin levels at the G1-S boundary and a func- 
tional calmodulin gene are required for the cell- 
cycle progression [6,7]. The proliferation of 
cultured cells is prevented or delayed by anti- 
calmodulin drugs [3,6]. 
Partial hepatectomy activates the proliferation 
of hepatocytes of the remaining liver, and DNA 
synthesis starts about 18 h after surgery. Previous 
studies suggested that cytosolic calcium controls 
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liver regeneration [1,8]. In addition, a calmodulin 
wave in liver regeneration has been observed be- 
tween 6 and 14 h after surgery, with maximum 
levels between 8 and 12 h after operation [9]. 
Delay of calmodulin wave and DNA synthesis by 
an anticalmodulin drug (trifluoperazine) indicates 
that both events may be related in liver regenera- 
tion [lo]. 
So far, the origin of the calmodulin wave in the 
pre-replicative phase of liver regeneration has re- 
mained unclear. It has been suggested that the 
increase in cytosolic calmodulin during liver re- 
generation may be due to an increased synthesis of 
the protein. Another possibility would be translo- 
cation of calmodulin from one cellular compart- 
ment to another (for example plasma membrane to 
cytosol) but it has been reported that calmodulin 
levels remain constant in the particulate fraction 
during liver regeneration [9]. A third possibility 
would be an altered calmodulin turnover. 
Our results strongly suggest that the cytosolic 
calmodulin wave observed after partial hepatec- 
tomy arises from de novo synthesis of the protein. 
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2. MATERIALS AND METHODS 
2.1. Animals 
Male Sprague-Dawley rats (7-8 weeks old) were used in all 
experiments. Animals were kept in a 12 h light-dark schedule 
with food and water provided ad libitum. Before surgery, per- 
formed under Ketolar@ anesthesia, animals were fasted for 
12 h. Sham operations were performed under identical condi- 
tions. Rats were killed by decapitation. Actinomycin D (Sigma, 
1 pg/g body wt) or cycloheximide (0.66 pg/g body wt) were in- 
jected into the tail vein, 1 or 3 h after surgery. 
2.2. Tissue extracts 
Liver tissues were homogenized in 10 vols of 125 mM borate, 
1 mM EGTA, 75 mM NaCl, pH 7.8 (Dounce homogenizer). 
After centrifugation (100000 x g), supernatants were heated 
(5 min, 95’C), cooled and re-centrifuged (50000 x g). Aliquots 
were frozen at - 20°C until use. 
2.3. Protein and calmodulin measurements 
Protein concentrations were measured according to Lowry et 
al. [l l] and Sedmak and Grossberg [12]. Calmodulin concentra- 
tions were determined by phosphodiesterase activation [13]. 
2.4. 2D-PAGE 
Purified proteins and extracts were labeled in vitro by reduc- 
tive methylation [14] using [%]formaldehyde (NEN, specific 
activity 52 Ci/mol), separated by ZD-PAGE according to 
O’Farrell 1151 and visualized by fluorography 1161. For isoelec- 
tric focusing, 20% Ampholine (LKB) pH 2.5-4 and 80% Am- 
pholine (LKB) pH 3.5-10 (linear gradient 4-7.5) were applied. 
2.5. RNA isolation 
Total RNA was obtained as described by Chirgwin et al. [17]. 
Poly(A+) RNA was prepared by affinity chromatography from 
total RNA according to Aviv and Leder [18]. 
2.6. RNA blot 
Total RNA (25 pg) or poly(A+) RNA (10 pg) were elec- 
trophoresed on gels containing 1.4% agarose and 6% for- 
maldehyde and blotted onto Biodyne membrane (Pall, Glen 
Cove, NY) as described by Thomas [19]. 
2.7. RNA dot blot 
Total or poly(A+) RNA were processed as described by Ber- 
chtold and Means 1201 according to Schloss et al. 1211. Nylon 
membranes (Biodyne, Pall Corp., Glen Cove, NY, USA) were 
hybridized and washed at high stringency as described in the 
manufacturer’s manual. Kodak and Fuji X-ray film were ex- 
posed at - 70°C and the signals were quantitated by measuring 
the absorbance of the film at 405 nm in a Virion Reader. 
2.8. Labeling of cDNA probes 
The following cDNA probes were used for hybridization: 
calmodulin cDNA [22], @actin cDNA [23] and parvalbumin 
cDNA [20]. Labeling was performed according to Feinberg and 
Vogelstein [24] resulting in a specific radioactivity of 2-3 x 
lo9 dpm/pg, and separated from free radioactivity by passage 
over a 1 ml Sephadex G50 column in 20 mM NaCI, 20 mM 
Tris-HCl, 2 mM EDTA, 0.25% SDS (pH 7.5). 
3. RESULTS AND DISCUSSION 
3.1. Effect of protein synthesis inhibitors on 
calmodulin levels 
Cycloheximide and actinomycin D were injected 
into hepatectomized rats and the appearance of 
calmodulin in the cytosolic fraction at different 
time points of the pre-replicative phase of liver 
regeneration was followed by 2D-PAGE. Calmo- 
dulin (fig.1, arrows) is characterized by a mole- 
cular mass of 18 kDa and an isoelectric point of 
approx. pH 4.1. Calmodulin spots in regenerating 
livers of rats injected with cycloheximide 
(fig. lB,G,D,I) or actinomycin D (fig. lC,H,E, J) 
are weaker than the ones observed in livers of 
hepatectomized (fig. lA,F) or laparotomized rats 
(not shown). 
Two general observations were made: (a) the 
calmodulin spot was weaker when cycloheximide 
was injected instead of actinomycin; (b) inhibitors 
injected 1 h after surgery caused a greater reduc- 
tion in the calmodulin spot than those injected 3 h 
after surgery. Strongest inhibition was observed 
when cycloheximide was injected 1 h after hepatec- 
tomy, and in some samples the calmodulin spot 
was not even detectable (fig.lB). 
The electrophoretic analysis was confirmed by 
quantitative measurement of cytosolic calmodulin 
by the phosphodiesterase activation method 
(fig.2). Calmodulin levels in regenerating livers of 
rats killed 8 and 12 h after partial hepatectomy are 
about twice that of control livers (mean value of 
non operated and laparotomized rats). When 
hepatectomized rats were injected with actino- 
mycin D, a non-significant diminution of calmo- 
dulin levels was observed, but when cycloheximide 
was injected, calmodulin levels were in the range of 
control levels, or even lower, as in the case of some 
Fig.1. 2D-PAGE of hepatic cytosol from hepatectomized rats: (A-E) killed 8 h after surgery and (F-J) killed 12 h after surgery. (A,F) 
No inhibitor injected; (B,G) injected with cycloheximide 1 h after surgery; (C,H) injected with actinomycin D 1 h after surgery; (D,I) 
injected with cycloheximide 3 h after surgery; (E,J) injected with actinomycin D 3 h after surgery. 
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Fig.2. Calmodulin measurement in hepatic cytosol by the 
phosphodiesterase method. Control livers (M); regenerating 
livers (0); regenerating livers of rats injected with actinomycin 
D 10); regenerating livers of rats injected with cycloheximide 
(Q). 
rats killed 8 h after surgery. This is in agreement 
with the 2D-PAGE analysis. 
3.2. Calmodulin mRNA measurement 
This study was performed from 0 to 8 h after 
surgery since the calmodulin wave has its max- 
imum at 8-12 h after hepatectomy. 
Calmodulin mRNA levels are not markedly 
changed 2 h after partial hepatectomy, but at 4, 6, 
and 8 h after surgery there is an increase of 
calmodulin mRNA, at 8 h being 151% of the value 
found in control livers (table 1). Measurement of 
@actin mRNA on the same Biodyne paper was 
used as a positive control since it has been describ- 
ed by Friedman et al. [25] that ,&actin increases 
Table I 
Increment of calmodulin and ,&actin mRNA measured in units 
of densitometric absorbance120 pg total RNA 
Time after 
suraerv (h) 
Calmodulin % &Actin % 
0 (Control) 800.2 * 16.6 100 669.0 + 88 100 
2 776.2 + 28.1 86 139.6 * 49 111 
4 824.2 + 12.8 114 991.0 * 79 148 
6 854.2 + 3.8 131 1296.2 * 57 194 
8 890.5 k 15.3 151 1278.7 + 372 191 
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Fig.3. Changes in calmodulin mRNA assessed by dot blot 
hybridization of 10 yg of poly(A+) RNA. (A) Calmodulin 
cDNA hybridization of samples from control and 
hepatectomized rats. (B) Calmodulin cDNA hybridization of 
samples from hepatectomized rats injected with actinomycin D 
(150 pg/150 g body wt) 1 h after surgery. (C) Calmodulin 
cDNA hybridization of rat testis poly(A+) RNA, used as 
standard. 
during liver regeneration. 8 h after surgery we 
measured a value of 191% compared to controls. 
Parvalbumin was chosen as a control for back- 
ground signals since it is not expressed in liver. 
Parvalbumin cDNA hybridization gave no signal 
in either control or regenerating livers. Calmodulin 
mRNA was also measured on poly(A+) RNA dot 
blots. Two groups of rats were used for this experi- 
ment: (i) hepatectomized rats killed 2, 4,6, and 8 h 
% 
160 
0 1 2 4 6 6 Hours 
f TIME AFTER HEPATECTOMY 
Fig.4. Calmodulin messenger RNA increase. (U) 
Hepatectomized rats; (A---A) hepatectomized rats injected 
with actinomycin D I h after surgery. 
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after surgery, and (ii) hepatectomized rats which 
were injected with actinomycin D and then killed 
at the same time intervals in the first group. Signals 
obtained from the first group were higher than the 
ones from the second group (fig.3). The first group 
shows a clear increase of calmodulin mRNA of 
171% with respect to the control value, but hepa- 
tectomized rats injected with actinomycin D ex- 
hibit a short and gradual increase of calmodulin 
mRNA reaching a maximum value of 134%. 
When protein synthesis was inhibited by cyclo- 
heximide, the levels of calmodulin dropped to 
normal (mean value of non-operated and laparoto- 
mized rats), indicating that the calmodulin wave is 
due to new translation of calmodulin. 
However, the effects of actinomycin D were 
more complex. Although calmodulin mRNA levels 
were strongly reduced in livers of hepatectomized 
rats treated with actinomycin D, calmodulin pro- 
tein levels did not change significantly. This 
discrepancy may be explained as follows: as shown 
in fig.4, hepatectomized rats injected with ac- 
tinomycin D exhibit a 30% increase of calmodulin 
mRNA levels compared to the control. It is possi- 
ble that this slight increase in mRNA is still suffi- 
cient to produce similar amounts of calmodulin in 
treated regenerating livers when translation is not 
inhibited. The 30% increase in calmodulin mRNA 
could be because (i) the dose of actinomycin D was 
not sufficient to completely block transcription, or 
(ii) there is an altered turnover rate of calmodulin 
mRNA in regenerating livers. 
Partial hepatectomy leads to the activation of a 
large number of cells, which subsequently enter the 
Gr phase of the cell cycle. The calmodulin wave 
previously described to take place in the pre- 
replicative phase of liver regeneration [9, lo], 
finishes at 16 h after surgery, i.e., 2 h prior to the 
beginning of DNA synthesis. It is probable that the 
role of calmodulin is related with the progression 
through the cell cycle as has been suggested in a 
previous report using Cl27 mouse cells transform- 
ed by a BPV vector containing the calmodulin gene 
[26]: elevated calmodulin levels affect the rate of 
cell proliferation by increasing the rate at which 
cells progress through Gr. 
Our results demonstrate that the calmodulin 
wave in liver regeneration is due to an elevated pro- 
tein production; translation as well as transcription 
are both increased. This is in agreement with 
observations from in vitro experiments, demon- 
strating new synthesis of calmodulin when quies- 
cent cultured cells (CHO-Kl) re-enter in the cell 
cycle [27]. 
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